Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
Fresenius Medical Care AG: A reportable insider transaction was published on 19th March 2025. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 19th March 2025,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna 
. The transaction toke place on 17th March 2025. . The aggregated volume was 39.557,69 EUR, based on an average price of 43,90 EUR. The nature of the Investment was not specified.
Fresenius Medical Care AG: A reportable insider transaction was published on 19th March 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 19th March 2024,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 18th March 2024. . The aggregated volume was 62.555,87 EUR, based on an average price of 34,93 EUR. The nature of the Investment was not specified.
Fresenius Medical Care AG: A reportable insider transaction was published on 15th December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 15th December 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 12th December 2023. The order was executed at the trading place Xetra. . The aggregated volume was 42.342,17 EUR, based on an average price of 38,53 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG: A reportable insider transaction was published on 15th December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 15th December 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 12th December 2023. The order was executed at the trading place CBOE DXE. . The aggregated volume was 15.043,50 EUR, based on an average price of 38,57 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG: A reportable insider transaction was published on 15th December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 15th December 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 12th December 2023. The order was executed at the trading place POSIT EU DK. . The aggregated volume was 3.693,12 EUR, based on an average price of 38,47 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG: A reportable insider transaction was published on 15th December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 15th December 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 12th December 2023. The order was executed at the trading place TRQS EU. . The aggregated volume was 4.823,75 EUR, based on an average price of 38,59 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 15th December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 15th December 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 12th December 2023. The order was executed at the trading place Xetra. . The aggregated volume was 42.342,17 EUR, based on an average price of 38,53 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 15th December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 15th December 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 12th December 2023. The order was executed at the trading place CBOE DXE. . The aggregated volume was 15.043,50 EUR, based on an average price of 38,57 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 15th December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 15th December 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 12th December 2023. The order was executed at the trading place POSIT EU DK. . The aggregated volume was 3.693,12 EUR, based on an average price of 38,47 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 15th December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 15th December 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 12th December 2023. The order was executed at the trading place TRQS EU. . The aggregated volume was 4.823,75 EUR, based on an average price of 38,59 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG: A reportable insider transaction was published on 6th December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 6th December 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 4th December 2023. . The aggregated volume was 198.714,19 EUR, based on an average price of 38,57 EUR. The nature of the Investment was not specified.
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 6th December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 6th December 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 4th December 2023. . The aggregated volume was 198.714,19 EUR, based on an average price of 38,57 EUR. The nature of the Investment was not specified.
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 21st March 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 21st March 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 16th March 2023. The order was executed at the trading place CBOE Europe. . The aggregated volume was 10.933,84 EUR, based on an average price of 36,81 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 21st March 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 21st March 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 16th March 2023. The order was executed at the trading place Turqoise Europe. . The aggregated volume was 11.199,36 EUR, based on an average price of 36,84 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 21st March 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 21st March 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 16th March 2023. The order was executed at the trading place XETRA. . The aggregated volume was 9.608,67 EUR, based on an average price of 36,81 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG & Co. KGaA: A reportable insider transaction was published on 21st March 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 21st March 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 16th March 2023. The order was executed at the trading place Aquis Exchange Europe. . The aggregated volume was 4.343,80 EUR, based on an average price of 36,81 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG: A reportable insider transaction was published on 21st March 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 21st March 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 16th March 2023. The order was executed at the trading place CBOE Europe. . The aggregated volume was 10.933,84 EUR, based on an average price of 36,81 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG: A reportable insider transaction was published on 21st March 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 21st March 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 16th March 2023. The order was executed at the trading place Turqoise Europe. . The aggregated volume was 11.199,36 EUR, based on an average price of 36,84 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG: A reportable insider transaction was published on 21st March 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 21st March 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 16th March 2023. The order was executed at the trading place XETRA. . The aggregated volume was 9.608,67 EUR, based on an average price of 36,81 EUR. The nature of the Investment was Buy.
Fresenius Medical Care AG: A reportable insider transaction was published on 21st March 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 21st March 2023,
The Insider Transaction was made by Mazur-Hofsäß, Dr. Katarzyna . The transaction toke place on 16th March 2023. The order was executed at the trading place Aquis Exchange Europe. . The aggregated volume was 4.343,80 EUR, based on an average price of 36,81 EUR. The nature of the Investment was Buy.
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.